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The first BµG@S microarray
Campylobacter jejuni is recognized as the lead-
ing cause of food-borne bacterial diarrhoeal disease
throughout the world [1]. In the UK it is predicted
that there are over half a million cases a year.
Campylobacter enteritis is a more protracted illness
than the Salmonella equivalent (5–10 days com-
pared with 24 h), so the cost to the UK economy
through lost working days is significant. Further-
more, infection with this bacterium has been impli-
cated as a frequent antecedent to the development
of the neurological diseases Guillain-Barre´ syn-
drome and Miller Fisher syndrome [5]. The natural
hosts for C. jejuni are avian species, where the bac-
terium is a commensal organism and does not cause
disease. Thus, C. jejuni readily colonizes chick-
ens and other poultry and thereby enters the food
chain. However, despite intensive study, including
the publication of the genome sequence of strain
NCTC 11168 in February 2000 [6], there have been
few advances in the development of control and
intervention strategies and the mechanism(s) by
which C. jejuni causes diarrhoeal disease are still
unclear.
A C. jejuni NCTC 11168 whole genome microar-
ray was the first array constructed at the BµG@S
facility. The first generation C. jejuni array uti-
lized the ordered plasmid library that was a by-
product of the genome sequencing project (per-
formed at the Sanger Institute, Cambridge, UK)
by selecting an optimum clone to represent each
gene in the genome and amplifying PCR prod-
ucts from these selected clones using a single pair
of vector primers [2]. This approach was selected
because it was inexpensive compared to purchasing
oligonucleotide primers to amplify gene-specific
PCR products and to validate microarray tech-
nology with respect to bacterial pathogens. This
low-cost microarray contained 34.5% gene-specific
probes, whilst the remainder contained either single
(35.4%) or multiple (30.1%) adjacent gene frag-
ments. Our aim has been to exploit this plasmid
clone array for both comparative genomic and gene
expression studies with C. jejuni.
Microarray-based epidemiology?
A comparative genomics study of 11 human iso-
lates revealed extensive genetic diversity between
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these C. jejuni strains [2]. Many of the strain-
variable genes are associated with the biosynthesis
of surface structures, including flagella, lipo-oligo-
saccharide and capsule. This suggests that varia-
tion of these determinants may be important in
survival, transmission and pathogenesis, indicating
that selective pressures have driven profound evo-
lutionary changes to create a diverse Campylobac-
ter species. Comparison of the capsule biosynthesis
locus reveals conservation of all the genes in this
region in strains with the same Penner serotype as
strain NCTC 11168. By contrast, between five and
17 NCTC 11168 genes in this region are either
absent or highly divergent in strains of a different
serotype to the sequenced strain, providing fur-
ther evidence that the capsule accounts for Penner
serotype specificity. In all, at least 21% of the
genes present in the sequenced strain appear dis-
pensable, as they are absent or highly divergent in
one or more of the isolates tested, defining 1300 out
of 1654 genes as C. jejuni species-specific. These
genes mainly encode housekeeping functions, such
as metabolic, biosynthetic, cellular and regulatory
processes. However, many virulence determinants
are also conserved, indicating that they are indis-
pensable for C. jejuni to cause disease in humans.
These include the cytolethal distending toxin, the
flagellar structural proteins, the PEB antigenic sur-
face proteins and the general protein glycosylation
locus.
C. jejuni strain diversity combined with vari-
able host responses results in a complex spec-
trum of disease outcomes, ranging from a symp-
tomatic colonization to severe inflammatory diar-
rhoea. A major reason for continued comparative
genomics studies is the absence of an animal model
that reflects C. jejuni-associated disease. Precise
strain comparisons from well-characterized strains
of diverse origins may allow correlates of patho-
genesis to be determined and the subsequent iden-
tification of potential virulence determinants. Also,
an understanding of genetic differences between
C. jejuni strains from different ecological niches
should allow the identification of improved epi-
demiological markers and the development of ratio-
nal approaches to reduce this problematic pathogen
from the food chain.
In addition to investigating human clinical iso-
lates of diverse origins, current projects are also
attempting to investigate differences in genomic
content of C. jejuni strains from a wider vari-
ety of sources. For example, multilocus sequence
typing (MLST) of C. jejuni strains has identified
two clonal complexes associated with the sand of
bathing beaches, and not with human disease cases,
livestock or chickens (K.E. Dingle, personal com-
munication). It is thought that the natural host of
these isolates may be wild birds, and that faecal
contamination of the beaches by birds preceded the
isolation of these strains, as a single isolate from
this source is placed in one of these complexes.
We predict that these strains are missing genes
that prevent them from causing human disease or
colonizing chickens. Using microarray analysis to
identify genes that are absent or highly divergent
in these clonal complexes may allow us to iden-
tify novel genes with an important role in human
virulence or chicken colonization. Another inter-
esting set of strains has been identified from the
recent Infectious Intestinal Diseases study by the
Foods Standards Agency, where some of the con-
trol patients were found to be carrying C. jejuni but
were asymptomatic. Microarray analysis of such
strains could highlight genes that may have a role
in causing human diarrhoeal disease.
Accurate transcription analysis?
In addition to comparative genomic studies, we
have also carried out gene expression-based stud-
ies. One of our main considerations has always
been to obtain meaningful data, and an important
contributing factor to this is the isolation of total
RNA that contains an mRNA population that repre-
sents the condition under investigation, rather than
conditions involved in the RNA isolation protocol.
Both high-speed centrifugation and lysing bacterial
cell walls are steps in current commercial RNA
isolation kits that will result in changes in gene
expression before mRNA stabilization. The use
of high concentrations of guanidine isothiocynate
for immediate chemical stabilization of mRNA,
as pioneered for RNA isolation from Mycobac-
terium species [4], is not possible for C. jejuni, as
the bacterial cells lyse under the highly denaturing
conditions. Therefore, we developed a protocol to
minimize RNA isolation protocol-induced changes
in C. jejuni gene expression. This incorporates a
short low-speed centrifugation of a 50 ml culture
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volume to quickly pellet a proportion of the bac-
terial cells, followed by a rapid disruption of the
cells and mRNA stabilization using the Hybaid
Ribolyser kit. The RNA is further purified using
the Qiagen RNeasy Mini kit to produce total RNA
suitable for microarray analysis. Additionally, we
always isolate our test and control RNA samples
at the same time, as a matched pair, to avoid the
effect of any day-to-day variation in the proto-
col. Using this protocol, we routinely isolate 50 µg
total RNA at a concentration of >1 µg/µl, which is
necessary to perform microarray hybridizations in
triplicate from the same sample. Comparing gene
expression profiles between the C. jejuni NCTC
11168 wild-type strain and a wlaC mutant has val-
idated this approach. WlaC is involved in protein
glycosylation (post-translational modification) and
thus mutation of the wlaC gene was predicted to
not affect gene expression. Microarray analysis has
shown that less than 10 genes appear to be up- or
downregulated in this mutant, suggesting that our
RNA isolation protocol produces mRNA, which
reflects the conditions under test rather than the
isolation protocol.
Currently we are investigating the effect of
changes in culture conditions on the gene expres-
sion profiles of the wild-type C. jejuni NCTC
11168 strain. Changes in culture conditions aim
to mimic environmental stresses that the bacteria
will encounter. For example, the body temperature
of avian species (the natural host for C. jejuni ) is
42 ◦C and the bacteria grow optimally at this tem-
perature, rather than at 37 ◦C. An obvious exper-
iment was to compare gene expression profiles at
the two temperatures; however, microarray analysis
has revealed relatively few changes in gene expres-
sion at 42 ◦C, with the most significant occurring
in metabolic pathways. For example, microarray
analysis indicates that the succinate dehydrogenase
operon (sdhABC ) is downregulated at 42 ◦C. Suc-
cinate dehydrogenase is a constituent of the tricar-
boxylic acid cycle, but the biochemical significance
of downregulation at 42 ◦C is unclear. Another area
of investigation has been the response of C. jejuni
to bile salt stress, which is a relevant in vivo stress
that C. jejuni must survive. We have studied gene
expression changes in the presence of the bile salt
deoxycholate at 37 ◦C and microarray analysis indi-
cates a greater change in gene expression. The most
interesting changes appear to affect the surface
structures of the bacteria and these are currently
under further investigation.
As well as varying the culture conditions to
induce changes in gene expression, comparing iso-
genic defined mutants against the wild-type strain
can give important clues to gene function. How-
ever, as shown with the wlaC mutant mentioned
above, not all mutations will have a dramatic
effect on gene expression, so careful selection of
mutants is required to maximize the information
that microarray analysis can provide. Therefore,
our initial studies have concentrated on strains with
defined mutations in known regulatory genes, such
as alternate sigma factors and two-component regu-
lators. Microarray analysis of such regulatory gene
mutants can confirm known roles for the gene prod-
uct in the control of gene expression (and thus par-
tially validate the microarray data) and also reveal
previously unknown functions. For example, we
have performed microarray analysis with defined
fliA, rpoN and flgR mutants, three genes known
to play a role in the regulation of flagellar biosyn-
thesis [3]. This has confirmed and expanded our
understanding of the regulation of gene expression
during flagellar biosynthesis, but also highlighted
the regulatory roles these genes play in flagellar-
independent pathways, which are now also under
further investigation.
The new hope?
The low-cost microarray used so far in our stud-
ies has given us an earlier insight into microar-
ray analysis of C. jejuni than would otherwise
have been possible. However, there are drawbacks
with this type of plasmid clone array. Not all the
reporter elements are gene-specific, so the pres-
ence of adjacent genes may increase the amount
of hybridization from the sample and thus increase
the signal intensity recorded, producing inaccu-
rate data. Also the melting temperatures of the
reporter elements are variable, resulting in uneven
hybridization profiles at any given temperature.
A gene-specific C. jejuni array with reporter ele-
ments designed using the BµG@S minimal cross-
hybridization protocol (which also designs PCR
products with similar melting temperatures) has
now been constructed, which also includes genes
absent in the NCTC 11168 genome. This second-
generation array begins the move away from a
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strain-specific array to a more representative array
of the C. jejuni species. Currently a second C.
jejuni strain (RM1221) is being sequenced at
TIGR [7] and genes present in this strain but absent
in NCTC 11168 will be included on a third-
generation array.
Microarray analysis of C. jejuni using both com-
parative genomic and gene expression analysis
approaches is allowing us to rapidly increase our
understanding of this enigmatic human pathogen.
We anticipate major steps forward in disease
control and intervention strategies, based on a
greater knowledge of the ecology, epidemiology
and pathogenesis of this organism. This should
enable us to get to the guts of the problem sooner
rather than later!!
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